Sangamo Therapeutics
Clinical trials sponsored by Sangamo Therapeutics, explained in plain language.
-
15-Year watch begins for transplant patients given 'Smart' immune cells
Disease control OngoingThis study follows 11 kidney transplant patients who received a special cell therapy (CAR-Treg) designed to prevent organ rejection. Researchers will track their health and kidney function for up to 15 years to see if the therapy remains safe and helps protect the transplanted ki…
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated May 26, 2026 06:18 UTC
-
Gene therapy patients monitored for years to ensure lasting safety
Disease control OngoingThis study follows 8 people with severe sickle cell disease or transfusion-dependent beta-thalassemia who already received a gene therapy called BIVV003 or ST-400. Researchers will check for side effects, survival, and how well the treatment controls their disease over many years…
Sponsor: Sangamo Therapeutics • Aim: Disease control
Last updated May 18, 2026 12:12 UTC